Table 1 Clinicopathological feature of NSCLC patients with circSLC25A16 expression.

From: Circular RNA circSLC25A16 contributes to the glycolysis of non-small-cell lung cancer through epigenetic modification

 

Total

circSLC25A16

p

Low = 13

High = 17

Gender

 Male

18

8

10

0.582

 Female

12

5

7

 

Age (years)

 ≥60

16

7

9

0.542

 <60

14

6

8

 

TNM

 I–II

10

6

4

0.020*

 III/IV

20

7

13

 

Lymph metastasis

 No

13

6

7

0.402

 Yes

17

7

10

 

Differentiation

 Well, moderate

13

8

5

0.187

 Poor

17

5

12

 
  1. *P < 0.05 represents statistical difference.
Back to article page